MAXHEAL introduced a third operational unit, viz. MAXHEAL Laboratories Pvt. Ltd., at the Special Economic Zone (SEZ) in Sachin, near Surat. This site is equipped with EU-GMP, WHO-GMP, NAFDAC, FDB (Ghana), and Ethiopia-approved facilities. Its infrastructure is par excellence, compatible with UK-MHRA standards, and a team of equally qualified personnel adds another feather to MAXHEAL’s cap.

The plant is well-connected by rail, road, and air transport and is located approximately 271 km from Mumbai.

Product Daily Production Capacity
Tablets 20,00,000 No./Shift
Capsules 10,00,000 No./Shift
Dry Syrup 10,000 Bottels/Shift
Svp-Ampules 1,00,000 No./Shift
Svp-Vials-10ml 40,000 No./Shift
Svp-Eyedrops 20,000 No./Shift
Dry powder Inj 40,000 No./Shift
Sachets 40,000 No./Shift
TOTAL SITE AREA 14,400 Sq Mt.
TOTAL CONSTRUCTED AREA 14,400 Sq Mt. - 2 Storey building
QC & QA AREA 850 Sq Mt
AREA AVAILABLE FOR EXPANSION 5100 Sq Mt.
FACILITIES Tablets, Capsules
EMPLOYEE STRENGTH 225 to 250
FACILITIES PLANNED Injectables, Oral Rehydration Salt, Dry Powder
ANNUAL MANUFACTURING CAPACITY Tablets 1000 million. Capsules 750 million
PROJECTED MANUFACTURING CAPACITY Tablets 1000 million, Capsules 750 million
ACCREDITATION'S WHO-cGMP, NAFDAC, FDB-Ghana